26 Apr 2017 | Livemint.com

BSE
NSE
Last Updated: Mar 31, 03:41 PM
Transgene Biotek Ltd.

BSE

  • 1.80 -0.02 (-1.1%)
  • Vol: 7855
  • BSE Code: 526139
  • PREV. CLOSE
    1.82
  • OPEN PRICE
    1.91
  • BID PRICE (QTY.)
    1.80(13476)
  • OFFER PRICE (QTY.)
    0.00(0)

NSE

  • (%)
  • Vol:
  • NSE Code:
  • PREV. CLOSE
  • OPEN PRICE
  • BID PRICE (QTY.)
    ()
  • OFFER PRICE (QTY.)
    ()

Transgene Biotek Ltd. Quarterly Results

Quarters
Select year
(Rs.in Million)
Particulars
Mar 2013
Mar 2012
Audited / UnAudited
UnAudited
UnAudited
Net Sales
6.15
53.06
Total Expenditure
7.34
50.66
PBIDT (Excl OI)
-1.19
2.40
Other Income
0.34
0.01
Operating Profit
-0.85
2.41
Interest
-0.92
1.24
Exceptional Items
NA
-81.07
PBDT
0.07
-79.90
Depreciation
7.39
0.97
Profit Before Tax
-7.32
-80.87
Tax
NA
-26.24
Provisions and contingencies
NA
NA
Profit After Tax
-7.32
-54.64
Extraordinary Items
NA
NA
Prior Period Expenses
NA
NA
Other Adjustments
NA
NA
Net Profit
-7.32
-54.64
Minority Interest
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
Consolidated Net Profit
-7.32
-54.64
Equity Capital
657.70
657.70
Face Value (IN RS)
10.00
10.00
Reserves
2561.66
NA
Basic Eps After Extraordinary Items
-0.11
-0.83
Basic Eps Before Extraordinary Items
-0.11
-0.83
No of Public Share Holdings
59342098.00
59336098.00
% of Public Share Holdings
90.22
90.22
 
NA
NA
PBIDTM% (Excl OI)
-19.35
4.52
PBIDTM%
-13.82
4.54
PBDTM%
1.14
-150.58
PBTM%
-119.02
-152.41
PATM%
-119.02
-102.98
 
Notes
Notes